Received Jun 23, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Flu like symptoms; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of influenza-like symptoms in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 24 hrs after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: Flu like symptoms). The outcome of the influenza-like symptoms was resolved. The reporter considered the influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date:16-JUN-2026 The patient did not recall any adverse event after the first dose of Shingrix. The batch number was not provided upon follow up with the reporter.